Tobias Huber

Professor University of Medical Center Hamburg-Eppendorf

Seminars

Tuesday 17th March 2026
Advancing Glomerular Disease Care Through Autoantibody Biomarkers
2:00 pm
  • Highlighting the role of podocyte-targeting autoantibodies in monitoring disease activity and guiding treatment decisions
  • Exploring novel biomarkers to enable earlier intervention and more precise therapeutic strategies
  • Showcasing global centers of excellence and international collaborations in autoimmune glomerular disease research
  • Discussing implications for pharmaceutical development and opportunities to accelerate drug discovery and clinical translation
Tobias Huber Speaker at 8th CKD Summit